Cara Therapeutics Announces Biomarker Data from KALM-1 and KALM-2 Trials of KORSUVA™ (difelikefalin) Injection Selected for Presentation at National Kidney Foundation Spring Clinical Meetings 2022
Poster highlights reduction in itch intensity with difelikefalin treatment correlated with reductions in inflammatory markers…
The third Hong Kong Shopping Festival extends into ASEAN for the first time
Focus Graphite Achieves up to 98.7% Carbon Concentrate Through Mechanical Processing and Activates Downstream Qualification Platform
DD.NYC Launches Full-Service Video Production Division
Launchit Solutions and Privacy Horizon Partner to Help Canadian Health Tech Companies Build, Govern, and Scale with Confidence
DesignRush Podcast, Carla Johnson Examines Why Innovation Claims Fail With Buyers